Australia's most trusted
source of pharma news
Posted 22 November 2021 PM
The last two sitting weeks of the federal parliamentary calendar kick off today with confirmation the much anticipated Zimmerman Inquiry report will be tabled during this time.
It's been 15 months since Health Minister Greg Hunt announced the House of Reps inquiry into approval processes for new drugs and novel medical technologies in Australia - paving the way for a radical shake-up of Australia's Health Technology Assessment (HTA) processes.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.